April 10 (Reuters) - Gilead Sciences Inc GILD.O:
GILEAD: FOR Q1, EXPECTS $253.4M IN ACQUIRED IPR&D EXPENSES
GILEAD: FOR Q1 , EXPECTS CHARGE OF ABOUT $0.16 TO BOTH GAAP AND NON-GAAP EPS, IN ACQUIRED IPR&D EXPENSES
Source text: [ID:]
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。